SGCG and influenza: Exploiting the differential kinetics of IFN expression, we next designed a study to determine whether mAb-mediated neutralization of type-I and type-II IFN pathways, either alone or in combination, could be used therapeutically following pneumococcal-influenza superinfection to enhance survival.